Skip to content

Artivion AORT Additional Paid-In Capital

Additional Paid-In Capital at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW
$2.78B+4.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$233.45M+7.5%
ITG
Integer HoldingsITGR
$755.87M+0.2%
Boston Scientific logo
Boston ScientificBSX
$21.58B+2.2%
IAR
Integra LifeSciencesIART
$1.34B+1.3%
BioLife Solutions logo
BioLife SolutionsBLFS
$710.81M+3.3%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's additional paid-in capital?
Artivion (AORT) reported additional paid-in capital of $526.26M in Q1 2026.
How has Artivion's additional paid-in capital changed year-over-year?
Artivion's additional paid-in capital increased by 35.3% year-over-year, from $388.83M to $526.26M.
What is the long-term trend for Artivion's additional paid-in capital?
Over 5 years (2020 to 2025), Artivion's additional paid-in capital has grown at a 10.3% compound annual growth rate (CAGR), from $316.19M to $516.6M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.